Prelude Therapeutics Inc (PRLD): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$1.29

Year ended 2025-12-31

2021-12-31 EPS (Diluted) (USD per share) 2025-12-31

Period ended	EPS (Diluted)	Change YoY	Source filing
2025-12-31	-$1.29	n/m	2026-03-10, From 2025-01-01
2024-12-31	-$1.68	n/m	2026-03-10, From 2024-01-01
2023-12-31	-$2.02	n/m	2025-03-10, From 2023-01-01
2022-12-31	-$2.44	n/m	2024-02-15, From 2022-01-01
2021-12-31	-$2.43	n/a	2023-03-15, From 2021-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Diluted)	Change YoY
Prelude Therapeutics Inc (PRLD)	2025-12-31	-$1.29	n/m
Emmaus Life Sciences, Inc. (EMMA)	2025-12-31	-$0.12	n/m
Jaguar Health, Inc. (JAGX)	2025-12-31	-$22.97	n/m
Evommune, Inc. (EVMN)	2025-12-31	-$11.22	n/m
Tonix Pharmaceuticals Holding Corp. (TNXP)	2025-12-31	-$14.57	n/m
Crescent Biopharma, Inc. (CBIO)	2024-12-31	-$0.59	n/m
CV Sciences, Inc. (CVSI)	2025-12-31	-$0.01	n/m
Pyxis Oncology, Inc. (PYXS)	2025-12-31	-$1.28	n/m
Arbutus Biopharma Corp (ABUS)	2025-12-31	-$0.17	n/m

Compare PRLD, EMMA, JAGX, EVMN side by side · Screen every company in Pharmaceutical Preparations ↗